Public Employees Retirement Association of Colorado’s Neurocrine Biosciences NBIX Stock Holding History

Public Employees Retirement Association of Colorado’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.06M	Buy	35,976 +26,000	+261%	+$3.86M	0.02%	403
2026 Q1	$1.31M	Hold	9,976	–	–	0.01%	605
2025 Q4	$1.42M	Hold	9,976	–	–	0.01%	585
2025 Q3	$1.4M	Sell	9,976 -439	-4%	-$59.5K	0.01%	583
2025 Q2	$1.31M	Sell	10,415 -574	-5%	-$65.8K	0.01%	595
2025 Q1	$1.22M	Hold	10,989	–	–	0.01%	614
2024 Q4	$1.5M	Sell	10,989 -124	-1%	-$15.3K	0.01%	579
2024 Q3	$1.28M	Hold	11,113	–	–	0.01%	616
2024 Q2	$1.53M	Sell	11,113 -447	-4%	-$61.3K	0.01%	552
2024 Q1	$1.59M	Sell	11,560 -124	-1%	-$16.9K	0.01%	563
2023 Q4	$1.54M	Sell	11,684 -236	-2%	-$27.2K	0.01%	563
2023 Q3	$1.34M	Sell	11,920 -837	-7%	-$88.1K	0.01%	579
2023 Q2	$1.2M	Hold	12,757	–	–	0.01%	650
2023 Q1	$1.29M	Hold	12,757	–	–	0.01%	625
2022 Q4	$1.52M	Hold	12,757	–	–	0.01%	586
2022 Q3	$1.35M	Hold	12,757	–	–	0.01%	610
2022 Q2	$1.24M	Hold	12,757	–	–	0.01%	621
2022 Q1	$1.2M	Sell	12,757 -1,283	-9%	-$109K	0.01%	679
2021 Q4	$1.2M	Hold	14,040	–	–	﹤0.01%	729
2021 Q3	$1.35M	Hold	14,040	–	–	0.01%	678
2021 Q2	$1.37M	Hold	14,040	–	–	0.01%	684
2021 Q1	$1.36M	Hold	14,040	–	–	0.01%	666
2020 Q4	$1.35M	Sell	14,040 -2	-0%	-$193	0.01%	635
2020 Q3	$1.35M	Hold	14,042	–	–	0.01%	593
2020 Q2	$1.71M	Sell	14,042 -723	-5%	-$79.9K	0.01%	518
2020 Q1	$1.28M	Hold	14,765	–	–	0.01%	540
2019 Q4	$1.59M	Hold	14,765	–	–	0.01%	575
2019 Q3	$1.33M	Hold	14,765	–	–	0.01%	625
2019 Q2	$1.25M	Sell	14,765 -154	-1%	-$12.6K	0.01%	657
2019 Q1	$1.31M	Sell	14,919 -3,251	-18%	-$272K	0.01%	649
2018 Q4	$1.3M	Sell	18,170 -158,546	-90%	-$15.2M	0.01%	672
2018 Q3	$21.7M	Sell	176,716 -17	-0%	-$1.93K	0.13%	158
2018 Q2	$17.4M	Sell	176,733 -50	-0%	-$4.48K	0.11%	183
2018 Q1	$14.7M	Sell	176,783 -1,616	-0.9%	-$136K	0.1%	203
2017 Q4	$13.8M	Sell	178,399 -105,644	-37%	-$7.21M	0.09%	227
2017 Q3	$17.4M	Sell	284,043 -231	-0.1%	-$12.2K	0.13%	175
2017 Q2	$13.1M	Buy	284,274 +140,981	+98%	+$6.84M	0.1%	211
2017 Q1	$6.21M	Sell	143,293 -35	-0%	-$1.5K	0.05%	323
2016 Q4	$5.55M	Buy	143,328 +123,740	+632%	+$5.6M	0.04%	348
2016 Q3	$992K	Sell	19,588 -1,695	-8%	-$84.4K	0.01%	816
2016 Q2	$967K	Buy	21,283 +15	+0.1%	+$691	0.01%	829
2016 Q1	$841K	Sell	21,268 -269	-1%	-$10.7K	0.01%	899
2015 Q4	$1.22M	Hold	21,537	–	–	0.01%	777
2015 Q3	$857K	Hold	21,537	–	–	0.01%	911
2015 Q2	$1.03M	Sell	21,537 -2,662	-11%	-$113K	0.01%	901
2015 Q1	$961K	Sell	24,199 -11,001	-31%	-$394K	0.01%	947
2014 Q4	$786K	Hold	35,200	–	–	0.01%	1033
2014 Q3	$552K	Hold	35,200	–	–	﹤0.01%	1164
2014 Q2	$522K	Hold	35,200	–	–	﹤0.01%	1231
2014 Q1	$567K	Hold	35,200	–	–	﹤0.01%	1188
2013 Q4	$329K	Hold	35,200	–	–	﹤0.01%	1451
2013 Q3	$398K	Hold	35,200	–	–	﹤0.01%	1321
2013 Q2	$471K	Buy	+35,200	New	+$432K	﹤0.01%	1223

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Public Employees Retirement Association of Colorado's NBIX Position: Q2 2026 in Review

Public Employees Retirement Association of Colorado increased its Neurocrine Biosciences (NBIX) stake by 261% in Q2 2026, buying an estimated $3.86M and bringing the position to 35,976 shares worth $6.06M. The position accounts for 0.02% of the portfolio, ranked #403.

Public Employees Retirement Association of Colorado first reported a position in NBIX in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.7M in Q3 2018. 771 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

Public Employees Retirement Association of Colorado held 35,976 shares of Neurocrine Biosciences worth $6.06M as of Q2 2026.
Public Employees Retirement Association of Colorado bought 26,000 Neurocrine Biosciences shares in Q2 2026, an estimated $3.86M.
Neurocrine Biosciences made up 0.02% of Public Employees Retirement Association of Colorado's portfolio in Q2 2026, its #403 holding.
Public Employees Retirement Association of Colorado first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 53 quarters since.
Public Employees Retirement Association of Colorado's Neurocrine Biosciences position peaked at $21.7M in Q3 2018.
771 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2026, filed 11 Aug 2026.